1 / 6

The Problem (dine at your own risk)

The Problem (dine at your own risk).

jaron
Télécharger la présentation

The Problem (dine at your own risk)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Problem(dine at your own risk) Of the 150 customers who ate dinner last night at the Palazzo di Sporcizie 66 had a fish entree, 72 a meat entree, the rest ate a vegan meal. Historically four in ten Palazzo’s customers who have a fish entree develop some stomach trouble within twelve hours of their meal. For meat eaters the rate is 3 in ten, while only one in ten vegans develops stomach trouble in that time limit. This morning at lunch you hear a person saying: “Yesterday I ate dinner at thePalazzo di Sporcizie , it was excellent, I had no trouble at all, except for the price.”Is the person you overheard most likely to be a fish eater, a meat eater, or a vegan?

  2. The Problem(Let’s be serious now) 150 Alzheimer’s disease (AD) patients recently participated in a research study. Four medications are currently approved by regulatory agencies such as the U.S.Food and Drug Administration (FDA) and the European Medicines Agency(EMA) to treat the cognitive manifestations of AD: three areacetylcholinesterase inhibitorsand the other ismemantine, anNMDA receptor antagonist. No drug has an indication for delaying or halting the progression of the disease.

  3. The Problem (Continued) 44% of the AD patients participating in the study received anacetylcholinesterase inhibitor, 48% were treated withmemantine,the remaining patients, due to their remarkably good physical conditions, received a placebo. Past research suggests that 40% of AD patients on an acetylcholinesterase inhibitor show remarkable improvement, thedrugmemantineimproves the conditions of about 30% of the patients treated with it, and 10% of AD patients in good physical conditions show improvement if left untreated. A patient picked at random from the 150 has shown no improvement. Which drug (or the placebo) is most likely to have been used with this patient?

  4. The Solution(s) The sample space S has 150 sample points (customers/AD patients)

  5. The Event of Interest is: • For Dining Customers : No stomach trouble • For AD patients : No improvement We do the calculations on the blackboard

  6. We need to compute: (They must be“givens.”)

More Related